Next, we analyzed the expression levels and subcellular biodistribution of SMURF2 in two different sets of prostate TMAs: PR1921 and HPro-Ade96Sur-01, containing in total 287 human normal and prostate adenocarcinoma (PRAD) tissue samples. The gene discussed is SMURF2; the disease is prostate adenocarcinoma.